Skip to content

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02673203
Enrollment
31
Registered
2016-02-03
Start date
2016-02-29
Completion date
2017-12-14
Last updated
2022-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

glucose monitoring, hunger levels, food intake

Brief summary

To investigate whether the daily glucose profiles as assessed by continuous glucose monitoring for 1 week of normal weight and obese individuals relate to hunger levels and food intake.

Detailed description

To evaluate the effect of blood glucose levels on eating behavior in a population of patients with diabetes in a free-living environment; the investigators plan to study lean healthy control subjects (BMI \<25 kg/m2) and obese non-diabetic subjects (BMI \> 30 kg/m2). The participants who qualify will be invited to use the CGMS (DEXCOM G4 Platinum) for up to 7 days. On the visit for placement of the CGMS: 1) the participants will be explained by one of the study physicians how to use a glucometer (FreeStyle or Accu-Check), 2) they will have the CGMS inserted under the skin, and 3) they will be instructed how to fill up the food log (informational brochures are available at the end of the protocol. On the second visit (up to 7 days after the initial visit) the CGMS will be removed from the skin and the glucose meter and food log will be returned to the investigators. When this study was initially designed, it incorporated 2 additional arms in the study: T1DM and obese T2DM patients. These patients were never recruited for the study.

Interventions

The CGMS consists of 3 parts: sensor, transmitter and monitor. The small sensor measures the glucose levels from the interstitial tissue. The transmitter is attached on top of the sensor and connects wirelessly to the monitor. The sensor is sterile and comes in an unopened package. It has a plastic wire-like tip that is placed under the skin and continuously measures the glucose levels. One of the study physicians will insert the CGMS wire-like tip under the volunteer's skin with the use of the DEXCOM sensor insertion kit. The transmitter is snapped to the sensor pod and the sensor/transmitter unit will be attached to the skin with an adhesive patch. The monitor is the size of a small hand-held device with a digital screen that displays a graph showing the glucose levels from the previous 4-24 hours.

BEHAVIORALFood log

The Food Record will ask about amount and type of food consumed throughout the day. The participants will also register how hungry they are before the meal and how full they feel after they ate, and type and duration of physical activity

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* A1c \< 10.5 %

Exclusion criteria

* BMI \<18 (no upper limit), * Creatinine \> 1.5 mg/dL, * Hgb \< 10 mg/dL, * ALT \> 2.5 X ULN, * untreated thyroid disease, * uncontrolled hypertension, * known neurological disorders, * untreated psychiatric disorders, * use of antidepressants and psychiatric medications, * use of weight loss medications in the 6 months prior to the study, * malignancy, * smoking, * current or recent steroid use in last 3 months, * history of current illicit drug use; * for women: pregnancy, or breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Changing Glucose Level3-5 daysThe CGM sensor measures the glucose levels from the interstitial tissue. Presented is the rate of changing glucose level (mg/dl/min).
Glucose Peak3-5 daysThe CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose peak (mg/dl).
Glucose Nadir3-5 daysThe CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose nadir (mg/dl).

Secondary

MeasureTime frameDescription
Nutirion Intake: Carbohydrate3-5 daysData were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily carbohydrate intake (g/day).
Difference in Glucose Peak and Nadir3-5 daysThe CGM sensor measures the glucose levels from the interstitial tissue. Presented is the difference in glucose peak and nadir (mg/dl).
Nutirion Intake: Protein3-5 daysData were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily protein intake (g/day).
Nutirion Intake: Fat3-5 daysData were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily fat intake (g/day).
Average Daily Hunger Rating3-5 daysAverage daily hunger was measured using a self-report scale. Hunger is measured on a scale from 1-10. 10 is the most hungry, 1 is the least hungry.
Nutirion Intake: Energy3-5 daysData were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily energy intake (kcal/day).

Countries

United States

Participant flow

Participants by arm

ArmCount
Typical Weight Participants
Participants with a BMI \<25 kg/m2.
16
Obese Non-diabetic Pariticpants
Non-diabetic participants with a BMI \> 30 kg/m2.
15
Total31

Baseline characteristics

CharacteristicTypical Weight ParticipantsTotalObese Non-diabetic Pariticpants
A1c (%)5.2 %
STANDARD_DEVIATION 0.4
5.1 %
STANDARD_DEVIATION 0.6
5.1 %
STANDARD_DEVIATION 0.7
Age, Continuous37.3 years
STANDARD_DEVIATION 12
39 years
STANDARD_DEVIATION 13
40.4 years
STANDARD_DEVIATION 14.1
BMI (kg/m2)23.5 kg/m2
STANDARD_DEVIATION 1.7
28.3 kg/m2
STANDARD_DEVIATION 5.4
33.4 kg/m2
STANDARD_DEVIATION 2.2
Race/Ethnicity, Customized
African American
1 Participants3 Participants2 Participants
Race/Ethnicity, Customized
Asian
2 Participants3 Participants1 Participants
Race/Ethnicity, Customized
Caucasian
11 Participants20 Participants9 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants5 Participants3 Participants
Region of Enrollment
United States
16 participants31 participants15 participants
Sex: Female, Male
Female
13 Participants25 Participants12 Participants
Sex: Female, Male
Male
3 Participants6 Participants3 Participants
Weight (kg)67.8 kg
STANDARD_DEVIATION 12
79.3 kg
STANDARD_DEVIATION 21.8
90.6 kg
STANDARD_DEVIATION 12.6

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 15
other
Total, other adverse events
0 / 160 / 15
serious
Total, serious adverse events
0 / 160 / 15

Outcome results

Primary

Glucose Nadir

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose nadir (mg/dl).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsGlucose Nadir85.1 mg/dl
Obese Non-diabetic PariticpantsGlucose Nadir87.1 mg/dl
Primary

Glucose Peak

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose peak (mg/dl).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsGlucose Peak119.5 mg/dl
Obese Non-diabetic PariticpantsGlucose Peak121.5 mg/dl
Primary

Rate of Changing Glucose Level

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the rate of changing glucose level (mg/dl/min).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsRate of Changing Glucose Level0.52 mg/dl/min
Obese Non-diabetic PariticpantsRate of Changing Glucose Level0.44 mg/dl/min
Secondary

Average Daily Hunger Rating

Average daily hunger was measured using a self-report scale. Hunger is measured on a scale from 1-10. 10 is the most hungry, 1 is the least hungry.

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsAverage Daily Hunger Rating5.8 score on a scale
Obese Non-diabetic PariticpantsAverage Daily Hunger Rating5.6 score on a scale
Secondary

Difference in Glucose Peak and Nadir

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the difference in glucose peak and nadir (mg/dl).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsDifference in Glucose Peak and Nadir34.3 mg/dl
Obese Non-diabetic PariticpantsDifference in Glucose Peak and Nadir33.9 mg/dl
Secondary

Nutirion Intake: Carbohydrate

Data were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily carbohydrate intake (g/day).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsNutirion Intake: Carbohydrate261.1 g/day
Obese Non-diabetic PariticpantsNutirion Intake: Carbohydrate251.8 g/day
Secondary

Nutirion Intake: Energy

Data were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily energy intake (kcal/day).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsNutirion Intake: Energy2251.5 kcal/day
Obese Non-diabetic PariticpantsNutirion Intake: Energy2167.8 kcal/day
Secondary

Nutirion Intake: Fat

Data were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily fat intake (g/day).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsNutirion Intake: Fat92.4 g/day
Obese Non-diabetic PariticpantsNutirion Intake: Fat97.5 g/day
Secondary

Nutirion Intake: Protein

Data were collected through food journals. Energy and macronutrient composition were calculated from self-reported food records based on Nutrition Data System for Research (NDS-R). Presented is the average daily protein intake (g/day).

Time frame: 3-5 days

ArmMeasureValue (LEAST_SQUARES_MEAN)
Typical Weight ParticipantsNutirion Intake: Protein99.9 g/day
Obese Non-diabetic PariticpantsNutirion Intake: Protein80.9 g/day

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026